The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.
SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.
The Magnolia, Texas, firm has seen rapid growth in recent years, being named to the Deloitte Technology Fast 500 in 2024 after logging revenue growth of 212% over a three-year period.
Sens. Tim Kaine, D-Va., and John Boozman, R-Ark., have introduced legislation to lift "arbitrary" caps on compensation for therapeutic and diagnostic medical physicists working in the VA.
Siemens self-reported a problem with software being inadvertently delivered to U.S. systems when the applications have not yet been cleared for use by the FDA.
The Los Angeles company previously announced it was acquiring Cimar UK in November, with a new SEC filing revealing further details about the purchase agreement.
Both structured reporting and AI support have been touted as promising solutions for streamlining workflows while also making radiologists' results more consistent.
The Federal Trade Commission was suing the pharmacy benefit manager over allegations it was deliberately inflating the price of insulin. Per the agreement, Express Scripts has agreed to end business practices that involved taking manufacturer rebates on wholesale drug costs without passing them on to patients.
Neither the health system nor the applications were named. Investigators with the U.S. Department of Health and Human Services Office of the Inspector General said they were able to perform a successful phishing attack and breach a portal lacking firewall support. The agency released a report containing the full details.
The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.
